Emerging targets in neuroinflammation-driven chronic pain

Area of Science:

• Neuroscience
• Immunology
• Pharmacology

Background:

• Current pain relievers primarily target neuronal signaling, with limited efficacy in halting disease progression.
• Neuroinflammation, involving immune cells and inflammatory mediators in the nervous system, is increasingly recognized as a key factor in chronic pain.
• Existing treatments often fail to address the underlying inflammatory processes contributing to persistent pain.

Purpose of the Study:

• To review emerging therapeutic targets for chronic pain that focus on modulating neuroinflammation.
• To highlight the role of specific molecular pathways and lipid mediators in spinal cord neuroinflammation and pain.
• To explore the potential of targeting neuroinflammation for treating chronic pain and associated neurological conditions.

Main Methods:

• Literature review of current research on neuroinflammation and chronic pain.
• Analysis of emerging molecular targets, including chemokines, proteases, and the WNT pathway.
• Examination of anti-inflammatory and pro-resolution lipid mediators and their mechanisms of action.

Main Results:

• Emerging targets like chemokines, proteases, and the WNT pathway are implicated in spinal cord neuroinflammation and chronic pain.
• Anti-inflammatory and pro-resolution lipid mediators demonstrate potential in resolving neuroinflammation, synaptic plasticity, and pain.
• Modulating neuroinflammation offers a promising strategy beyond traditional pain transduction targets.

Conclusions:

• Targeting excessive neuroinflammation presents a novel therapeutic avenue for chronic pain.
• This approach may also benefit patients with related neurological and psychiatric disorders.
• Further research into these emerging targets and mediators is warranted for effective pain management.